Back to Journals » Vascular Health and Risk Management » Volume 3 » Issue 4

Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors

       
Total article views   HTML views PDF downloads Totals
6,972 Dovepress* 6,972+ 2,624 9,596
Totals 6,972 2,624 9,596
*Since 15 September 2007
+Since July 2016

View citations on Google Scholar